Azurity Pharmaceuticals to Acquire Matinas BioPharma Nanotechnologies

Laura Testa North America Legal Chronicle
Tagged:

Lowenstein has advised Matinas in the sale of Matinas BioPharma Nanotechnologies to Azurity Pharmaceuticals. Matinas BioPharma has entered into a definitive stock purchase agreement to sell…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Laura Testa

Author: Laura Testa

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here